A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma.
Suzuki T, Kusumoto S, Kamezaki Y, Hashimoto H, Nishitarumizu N, Nakanishi Y, Kato Y, Kawai A, Matsunaga N, Ebina T, Nakamura T, Marumo Y, Oiwa K, Kinoshita S, Narita T, Ito A, Inagaki A, Ri M, Komatsu H, Aritsu T, Iida S.
Suzuki T, et al. Among authors: oiwa k.
Int J Hematol. 2023 Jun;117(6):900-909. doi: 10.1007/s12185-023-03550-w. Epub 2023 Feb 15.
Int J Hematol. 2023.
PMID: 36790667
Free PMC article.